Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, November 29, 2023.
Recursion Pharmaceuticals, Inc. - Class A (NASDAQ:RXRX)
Crossroads (+60) - RXRX is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid RXRX?
MarketClub looks at technical strength and momentum to determine if the timing is right for RXRX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for RXRX
The long-term trend has been DOWN since Oct 12th, 2023 at 6.440
The intermediate-term trend has been UP since Nov 14th, 2023 at 6.240
The short-term trend has been UP since Nov 29th, 2023 at 7.055
Smart Scan Analysis for RXRX
Based on our trend formula, RXRX is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 7.3900 | 7.8000 | 7.2111 | 7.2621 | +0.2421 |
| Prev. Close | Volume | Bid | Ask | Time |
| 7.0200 | 4056390 | 2023-11-29 12:54:14 |
| 52wk High | 16.745 | 52wk High Date | 2023-07-19 |
| 52wk Low | 4.54 | 52wk Low Date | 2023-05-02 |
| Average Volume | 4,816,648 | Shares Outstanding | 215,874 |
| Assets | 630,825,000M | Liabilities | 192,858,000M |
| P/E Ratio | -6.11720000 |